ALBUQUERQUE, NM – June 26, 2025 – Lovelace Medical Group (LMG) otolaryngologist Jason Mudd, MD, recently implanted his 100th Inspire® device used to treat obstructive sleep apnea (OSA) in patients who cannot tolerate nor benefit from CPAP therapy. Inspire® works by stimulating the tongue muscle to prevent airway obstruction during sleep. The system is fully implanted and controlled with a handheld remote.
“Inspire® therapy is the first FDA-approved OSA therapy that works comfortably inside the body,” said Dr. Mudd. “The implant delivers gentle pulses to the airway muscles to keep the airway open, so patients can breathe regularly and sleep soundly. It’s a game-changer for my patients who cannot tolerate a CPAP.”
To learn more about Lovelace Health System and its commitment to providing quality and state-of-the art surgical services care, please visit lovelace.com. To make an appointment with a Lovelace Medical Group ear, nose and throat provider, please call 505-727-1670.
Contact:
Whitney Alcantar, Lovelace Health System
whitney.alcantar@lovelace.com
Mobile: 505.903.0367
Lovelace Medical Group
Lovelace Medical Group (LMG) is a multispecialty group of more than 300 providers, including physicians and advanced practice providers serving a broad range of specialties and primary care. LMG provides patients with exceptional health care through its 30+ health care clinics and the support of Lovelace Health System hospitals and technology. LMG has earned recognition by National Committee for Quality Assurance Patient-Centered Medical Home (PCMH) for the last eight years and has a National Accreditation Program for Breast Cancers. New Mexico Heart Institute/Lovelace Medical Group brings more than 34 years of diagnostic, interventional and preventive cardiovascular expertise to our community and state. To learn more about the experience and skilled providers of Lovelace Medical Group, visit lovelacemedicalgroup.com.
###